Article info

other Versions

PDF
Original Article
Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study

Authors

  1. Correspondence to Professor Simon R Johnson, Division of Respiratory Medicine, University of Nottingham, Respiratory Medicine, Queens Medical Centre, Nottingham NG7 2UH, UK; simon.johnson{at}nottingham.ac.uk
View Full Text

Citation

Bee J, Fuller S, Miller S, et al
Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study

Publication history

  • Received August 7, 2017
  • Revised September 19, 2017
  • Accepted October 2, 2017
  • First published October 9, 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.